GeneDx and Mirum to provide genetic tests for cholestasis, cataracts or PBD-ZSD

​

GeneDx and Mirum Pharmaceuticals have partnered to provide no-cost exome sequencing for eligible patients across cholestasis, early-onset cataracts, and PBD-ZSD testing programmes.

The post GeneDx and Mirum to provide genetic tests for cholestasis, cataracts or PBD-ZSD appeared first on Hospital Management.

 

Back to the Featured Stories

Connect with us

Whether you are a professional looking for a new job or a representative of an organization who needs workforce solutions - we are here to help.